
Google’s own advanced AI technology, Bard, made a statement indicating that it considers the company to have a monopolistic position within the digital advertising market when asked to provide its verdict on the Justice Department’s antitrust litigation against Google.
The launch of Bard in the US on Tuesday was met with enthusiasm – only to be followed by an unexpected response, reported The New York Post. When app researcher and tech blogger Jane Manchun Wong posted screenshots of her exchanges with Bard.
“Google has a monopoly on the digital advertising market, and this has allowed the company to engage in anticompetitive behavior,” Bard said in response to Wong’s question on whether it supported the DOJ or Google in the case.
Bard claims that Google’s acquisitions and other activities in digital advertising have had negative impacts on consumers and inhibited market innovation— and said it “would side with the Justice Department.”
Read more: Google Health Looks to Handle Consumer Data With AI
The theoretical verdict quickly led Google to disavow its own creation as it battles AI rival ChatGPT.
“As we’ve said, Bard can sometimes give inaccurate or inappropriate information that doesn’t represent Google’s views and Bard should not respond in a way that endorses a particular viewpoint on subjective topics,” the company said in a statement to The Post.
Google added that Bard “trains” on publicly available content and its responses “can reflect positive or negative views of specific politicians, celebrities or other public figures, or even incorporate views on certain sides of controversial social or political issues into their responses.”
Featured News
Federal Reserve Greenlights Capital One’s $35.3 Billion Acquisition of Discover
Apr 18, 2025 by
CPI
Google to Appeal Partial Ruling in DOJ Antitrust Case
Apr 18, 2025 by
CPI
Indian Ad Agencies Warned Against WhatsApp Discussions After Antitrust Raids
Apr 17, 2025 by
CPI
US Court Ruling Against Google Spurs Fresh Antitrust Tensions in Europe
Apr 17, 2025 by
CPI
AstraZeneca Accused of Stifling Biosimilar Competition for Rare Disease Drug
Apr 17, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – The Airline Industry
Apr 10, 2025 by
CPI
Boosting Competition in International Aviation
Apr 10, 2025 by
Jeffrey N. Shane
Reshaping Competition Policy for the U.S. Airline Industry
Apr 10, 2025 by
Diana L. Moss
Algorithmic Collusion in the Skies: The Role of AI in Shaping Airline Competition
Apr 10, 2025 by
Qi Ge, Myongjin Kim & Nicholas Rupp
Competition in U.S. Airline Markets: Major Developments and Economic Insights
Apr 10, 2025 by
Germán Bet